HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Juha O Rinne Selected Research

Raclopride

8/2010Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
9/2008Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function.
9/2007Effects of intravenous glucose on dopaminergic function in the human brain in vivo.
11/2003Altered dopamine D2 receptor binding in atypical facial pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD

Juha O Rinne Research Topics

Disease

15Alzheimer Disease (Alzheimer's Disease)
08/2010 - 12/2002
15Parkinson Disease (Parkinson's Disease)
01/2010 - 10/2002
5Dementia (Dementias)
01/2010 - 01/2002
2Overweight
09/2008 - 09/2007
1Poisoning
08/2010
1Inflammation
03/2010
1Disease Progression
02/2010
1Stroke (Strokes)
12/2009
1Atrophy
11/2008
1Familial Cerebral Amyloid Angiopathy
04/2008
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
04/2008
1Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia)
09/2004
1Premature Menopause
09/2004
1Parkinsonian Disorders (Parkinsonism)
09/2004
1Mitochondrial Diseases (Mitochondrial Disease)
09/2004
1CADASIL
05/2004
1Facial Pain (Myofacial Pain)
11/2003
1Burning Mouth Syndrome (Syndrome, Burning Mouth)
01/2003
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2003
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
06/2002
1Tics (Tic)
01/2002

Drug/Important Bio-Agent (IBA)

7Amyloid (Amyloid Fibrils)IBA
04/2010 - 04/2008
7Glucose (Dextrose)FDA LinkGeneric
02/2010 - 01/2003
6Dopamine (Intropin)FDA LinkGeneric
09/2007 - 11/2002
5Levodopa (L Dopa)FDA LinkGeneric
08/2010 - 10/2002
52- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
10/2009 - 01/2008
4RacloprideIBA
08/2010 - 11/2003
3Deoxyglucose (2 Deoxy D glucose)IBA
12/2009 - 01/2003
2Carbon MonoxideIBA
08/2010 - 01/2003
2N- methyl- 2- (4'- methylaminophenyl)- 6- hydroxybenzothiazoleIBA
04/2010 - 04/2008
2CarbonIBA
10/2008 - 04/2008
2Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
11/2004 - 11/2003
1RadiopharmaceuticalsIBA
08/2010
1bapineuzumabIBA
04/2010
1CH3OCF2CH(CF3)OCH2FIBA
03/2010
1GABA-A Receptors (GABA(A) Receptor)IBA
03/2010
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2010
1CoffeeIBA
09/2009
1Dihydroxyphenylalanine (Dopa)IBA
07/2006
1rasagiline (Azilect)FDA Link
04/2006
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2006
1FLB 457IBA
11/2004
1ApolipoproteinsIBA
09/2004
1Matrix MetalloproteinasesIBA
09/2004
1Matrix Metalloproteinase 3 (Stromelysin 1)IBA
09/2004
1Mitochondrial Proteins (Mitochondrial Protein)IBA
09/2004
1Mitochondrial DNA (mtDNA)IBA
09/2004
1Presenilin-1IBA
03/2004
1Caffeine (No Doz)FDA LinkGeneric
02/2004
1Purinergic P1 Receptors (Adenosine Receptor)IBA
02/2004
1NNC 0756 (odapipam)IBA
11/2003
1tebufenozide (Mimic)IBA
01/2003
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2003
1Staphylococcal Protein A (A, Protein)IBA
01/2003
1catechol (pyrocatechol)IBA
01/2003
1TransferasesIBA
01/2003
1rivastigmine (Exelon)FDA LinkGeneric
12/2002
1donepezil (Aricept)FDA LinkGeneric
12/2002
1AcetylcholinesteraseIBA
12/2002
1Messenger RNA (mRNA)IBA
11/2002
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
11/2002
1fluorodopa F 18IBA
10/2002
1Estradiol (Estrace)FDA LinkGeneric
06/2002
1ProgesteroneFDA LinkGeneric
06/2002
1Deoxycytidine (CDR)IBA
01/2002